Literature DB >> 25793929

Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.

Karim Farid1, Xavier Poullias, Marco Alifano, Jean-Francois Regnard, Vincent Servois, Nadine Caillat-Vigneron, Slavomir Petras.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the effect of 2-((18)F)-fluoro-2-deoxy-D-glucose ((18)F-FDG)-PET/computed tomography (CT) respiratory-gated imaging [four-dimensional (4D)] in the metabolic evaluation of small solitary pulmonary nodules and analyze the cutoff maximum standardized uptake value (SUV(max)) of 2.5 in classifying and distinguishing benign/malignant pulmonary pathologies in 4D studies.
MATERIALS AND METHODS: Thirty-two patients with pulmonary lesions measuring 2 cm or less were included during their scheduled (18)F-FDG PET/CT examinations. The whole-body PET/CT acquisition (3D) was followed by a chest-centered PET/CT (4D) study synchronized with the respiratory cycle. The SUV(max) percentage difference (%Diff SUV(max)) was calculated. The nodule size, localization, and relationships with histological/cytological findings were studied.
RESULTS: Fifteen nodules were 10 mm or smaller and 17 were larger than 10 mm [mean size = 12 mm (7-20)]. The mean 3D-SUV(max) was 2.5 (0.7-6.1) and the mean 4D-SUV(max) 3.2 (0.9-7.2) (P < 0.001). The mean %Diff SUV(max) was 38% for all patients (7-90), 45% in subcentimetric (7-90%) and 31% (7-75%) in supracentimetric lesions (P = NS). Histology was obtained in 23/32 (72%) cases and the pathologic benign/malignant ratio was 4/19. Malignancies were diagnosed as lung adenocarcinoma, solitary metastases, large cell lung carcinoma, and sarcoma in 13 (41%), 3 (9%), 2 (6%), and 1 (3%) case, respectively. Malignant lesions showed mean 4D-SUV(max) of 3.8 (1.2-7.2). The cutoff SUV(max) of 2.5 did not classify and distinguish between benign/malignant pulmonary pathologies, neither in 3D nor in 4D studies.
CONCLUSION: Respiratory gating improves the detectability and metabolic evaluation of solitary pulmonary nodules, mostly those that are subcentimetric. However, as expected, the cutoff SUV(max) of 2.5 does not distinguish between benign/malignant lesions in either 4D or 3D studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25793929     DOI: 10.1097/MNM.0000000000000311

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Authors:  Orazio Schillaci; Ferdinando F Calabria
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Prone position [18F]FDG PET/CT to reduce respiratory motion artefacts in the evaluation of lung nodules.

Authors:  Hyung Ju Lee; Hye Joo Son; Mijin Yun; Jung Won Moon; Yoo Na Kim; Ji Young Woo; Suk Hyun Lee
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

Review 3.  Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.

Authors:  Russell Frood; Garry McDermott; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

4.  Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRI.

Authors:  Nils Martin Bruckmann; Julian Kirchner; Janna Morawitz; Lale Umutlu; Wolfgang P Fendler; Ken Herrmann; Ann-Kathrin Bittner; Oliver Hoffmann; Tanja Fehm; Maike E Lindemann; Christian Buchbender; Gerald Antoch; Lino M Sawicki
Journal:  EJNMMI Phys       Date:  2022-02-07

5.  Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions.

Authors:  Cinzia Crivellaro; Luca Guerra
Journal:  Curr Radiopharm       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.